Xencor (XNCR)- John R. Desjarlais, Sr. VP Research & CSO, sold 16,294 shares at $21.73. The total value of the transaction was $354,065. Desjarlais still owns 28,640 shares of XNCR.
Illumina (ILMN)- Robert S. Epstein, Director, sold 300 shares at $170.27. The total value of the transaction was $51,081. Epstein still owns 7,224 shares of ILMN.
Seattle Genetics (SGEN)- Eric Dobmeier, COO, sold 12,589 shares at $48. The total value of the transaction was $604,272. Dobmeier still owns 58,767 shares of SGEN.
Arrowhead Pharmaceuticals (ARWR)- Kenneth A. Myszkowski, CFO, sold 14,000 shares in two separate transactions. Myszkowski sold 13,100 shares at $8; and 6,900 shares at $8. Myszkowski still owns 115,689 shares of ARWR.
Amphastar Pharmaceuticals (AMPH)- Jason B. Shandell, President & General Counsel, sold 10,000 shares at $19.95. The total value of the transaction was $199,500. Shandell still owns 202,961 shares of AMPH.
Alexion Pharmaceuticals (ALXN)- Alvin S. Parven, Director, sold 15,700 shares in two separate transactions. Parven sold 15,000 shares at $136.53 and 700 shares at $135.51. Parven still owns 6,373 shares of ALXN.